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Identity 
Other names: KIAA1266 




The human MTA3 gene was identified through 
sequence homologies to other members of the MTA 
gene family (human MTA1, human MTA2, murine 
MTA3).  
The human MTA3 gene is composed of 14 exons. The 
MTA3 promoter sequence contains SP1, AP1, and 
oestrogen receptor binding sites (ER half sites). 
Transcription 
Two open reading frames of 1785 bp (isoform 1; 594 
AA; MTA3L) and 1548 bp (isoform 2; 515 AA; 
MTA3S, MTA3) were identified and predicted to be 
transcribed. The smaller isoform (MTA3S = MTA3) 
appears to be the most abundantly expressed isoform at 





Genomic organization of the human MTA3 gene. The intron/exon structure of MTA3 with start (ATG) and stop (TAA) codons indicated. 
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Domain structure of the MTA3 protein. BAH (bromo-adjacent homology) domain: putative protein-protein interaction domain, involved in 
gene silencing; ELM (Egl-27 and MTA1 homology) domain: unknown function; SANT (SWI3, ADA2, N-CoR and TFIIIB B) domain: 




MTA3 functions as a transcriptional repressor by 
interacting with histone deacetylases and nucleosome 
remodelling complexes such as Mi-2/NuRD. 
Expression 
MTA3 expression has been found in normal human 
breast, ovarian, and endometrial epithelial cells, in 
malignant breast, ovarian, and endometrial cancer cells
and cancer cell lines, in trophoblast cells and chorionic 
cancer cell lines, in germinal centre B cells, and i  B 
cell-derived lymphomas. A tissue distribution analysis 
of MTA3 expression in mice revealed an even more 
widespread distribution of MTA3 in the developing 
embryo and in adult tissues (heart, brain, spleen, lung, 
liver and kidney). In humans, MTA3 expression 
appears to be absent from fibroblasts. 
Localisation 
MTA3 exhibits primarily a nuclear localisation, 
although additional cytoplasmic localisation has been 
described. 
Function 
In epithelial cells, MTA3 maintains the expression f 
E-cadherin through the suppression of the E-cadherin 
inhibitor SNAIL. Expression of MTA3 is regulated by 
oestrogens via direct binding of the oestrogen receptor 
to the MTA3 promoter and is thus involved in the 
generation and maintenance of oestrogen-dependent 
epithelia such as the breast ductal epithelium and the 
ovarian surface epithelium. 
Mammary gland development 
Animal experiments revealed involvement of MTA3 
expression in mammary gland morphogenesis mediated 
by the suppression of the Wnt4 signalling pathway and
upregulation of epithelial cell adhesion proteins such as 
E-cadherin. 
Normal mammary gland development, as confirmed 
and studied by several knock out and knock in mouse 
models, relies on the concerted and correct integraion 
of divers signalling pathways, including the Wnt 
signalling pathway. Secretion of Wnt factors and their 
binding by mammary epithelial cells is necessary for 
correct gland development and its deregulation has 
been described to be involved in tumorigenesis. MTA3 
has been shown to inhibit Wnt4 expression by its 
transcriptional repression function, causing reduce 
Wnt4 secretion and subsequent lower beta-catenin 
levels. Therefore, based on the observations made with 
transgenic mouse models, expression of MTA3 in 
mammary epithelial cells has been associated with the 
inhibition of ductal branching in virgin and pregnant 
murine mammary glands. 
Epithelial cancer 
Deregulation of MTA3 expression in epithelial breast 
cancer, endometrial cancer, and ovarian cancer is 
associated with cancer progression by promoting the 
epithelial-mesenchymal transition (EMT). It is 
principally believed that reduced expression of MTA3 
allows higher expression levels of SNAIL and SLUG, 
two repressors of metastasis-associated cell adhesion 
proteins such as E-cadherin and occludin. 
Haemangiogenesis and lymphomagenesis 
A high expression level of MTA3 was found in 
germinal centre B lymphocytes, suggesting an 
involvement in B cell maturation by direct interaction 
with BCL6. BCL6 (B-cell lymphoma-6) is a 
transcriptional repressor that is co-expressed with 
MTA3 in the germinal centre, where normal B cells 
proliferate and undergo maturation. BCL6 functions as 
a transcriptional repressor and suppresses, in 
cooperation with MTA3, the expression of PRDM1 (Pr 
domain-containing protein 1), a master regulator of 
plasma cell differentiation. Overexpression of BCL6 is 
often observed in lymphomas, especially in large B-cell 
lymphomas. Thus, the cooperative action of BCL6 
together with MTA3 is believed to block differentiation 
of large B-cell lymphomas, facilitating 
lymphomagenesis. 
Placenta development 
A high expression level of MTA3 in trophoblast cells 
and trophoblast tumour cells suggests  
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The MTA3 regulation network.  
A. Breast ductal epithelia cells; epithelial cancer cells.  
B. Germinal center B lymphocytes; B cell-derived lymphomas. The regulation of MTA3 expression and its target genes by transcriptional 
activators (green) and transcriptional repressors (red) is shown. ER: oestrogen receptor. 
 
involvement of MTA3 in placenta development and 
homeostasis. However, the exact role of MTA3 
expression for placenta development and the 
downstream targets of MTA3 in trophoblast cells are
unknown and have to be elucidated. 
Homology 
MTA3 exhibits a high homology to human MTA1, 




MTA3 expression is significantly reduced in 
endometrioid adenocarcinomas of poor differentiation, 
although not associated with patients' survival. 
Ovarian cancer 
Note 
MTA3 expression is reduced in ovarian cancer with 
poor differentiation, although not at significant levels. 
Breast cancer 
Note 
Although extensively studied on breast cancer cells and 
tissues, revealing a close correlation of MTA3 
expression with oestrogen receptor expression, no 
studies have yet shown a direct association of MTA3 
expression with clinicopathological parameters in 
breast cancer. 
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